1
|
Khoury JD, Solary E, Abla O, Akkari Y,
Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, et
al: The 5th edition of the World Health Organization Classification
of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic
Neoplasms. Leukemia. 36:1703–1719. 2022.PubMed/NCBI View Article : Google Scholar
|
2
|
Union for International Cancer Control
(UICC): TNM Classification of Malignant Tumors. Brierley JD,
Gospodarowicz MK, Wittekind C (eds): 8th edition. Wiley-Blackwell,
Hoboken, NJ, 2017.
|
3
|
Kayser S, Döhner K, Krauter J, Köhne CH,
Horst HA, Held G, von Lilienfeld-Toal M, Wilhelm S, Kündgen A,
Götze K, et al: The impact of therapy-related acute myeloid
leukemia (AML) on outcome in 2853 adult patients with newly
diagnosed AML. Blood. 17:2137–2145. 2011.PubMed/NCBI View Article : Google Scholar
|
4
|
Hulegårdh E, Nilsson C, Lazarevic V,
Garelius H, Antunovic P, Rangert Derolf Å, Möllgård L, Uggla B,
Wennström L, Wahlin A, et al: Characterization and prognostic
features of secondary acute myeloid leukemia in a population-based
setting: A report from the Swedish Acute Leukemia Registry. Am J
Hematol. 90:208–214. 2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Granfeldt Østgård LS, Medeiros BC,
Sengeløv H, Nørgaard M, Andersen MK, Dufva IH, Friis LS, Kjeldsen
E, Marcher CW, Preiss B, et al: Epidemiology and clinical
significance of secondary and therapy-related acute myeloid
leukemia: A national population-based cohort study. J Clin Oncol.
33:3641–3649. 2015.PubMed/NCBI View Article : Google Scholar
|
6
|
Strickland SA and Vey N: Diagnosis and
treatment of therapy-related acute myeloid leukemia. Crit Rev Oncol
Hematol. 171(103607)2022.PubMed/NCBI View Article : Google Scholar
|
7
|
Kaira K, Naruse I, Shinomiya S and Kagamu
H: Occurrence of hematological malignancy in long-term survivors
with advanced thymic cancer. In Vivo. 34:1511–1513. 2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Engels EA: Epidemiology of thymoma and
associated malignancies. J Thorac Oncol. 5 (10 Suppl 4):S260–S265.
2010.PubMed/NCBI View Article : Google Scholar
|
9
|
Fianchi L, Pagano L, Piciocchi A, Candoni
A, Gaidano G, Breccia M, Criscuolo M, Specchia G, Maria Pogliani E,
Maurillo L, et al: Characteristics and outcome of therapy-related
myeloid neoplasms: Report from the Italian network on secondary
leukemias. Am J Hematol. 90:E80–E85. 2015.PubMed/NCBI View Article : Google Scholar
|
10
|
Morton LM, Dores GM, Tucker MA, Kim CJ,
Onel K, Gilbert ES, Fraumeni JF Jr and Curtis RE: Evolving risk of
therapy-related acute myeloid leukemia following cancer
chemotherapy among adults in the United States, 1975-2008. Blood.
121:2996–3004. 2013.PubMed/NCBI View Article : Google Scholar
|
11
|
Vogt A, Schmid S, Heinimann K, Frick H,
Herrmann C, Cerny T and Omlin A: Multiple primary tumours:
Challenges and approaches, a review. ESMO Open.
2(e000172)2017.PubMed/NCBI View Article : Google Scholar
|
12
|
Alghanmi HA: Successful treatment of
synchronous double lung primary malignancies and colon cancer.
Cureus. 14(e22552)2022.PubMed/NCBI View Article : Google Scholar
|
13
|
Hirano T and Eto K: Harlequin cells.
Blood. 132(766)2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Jain G, Kumar C and Chopra A: Harlequin
cell: Ubiquitous or pathognomic? Int J Lab Hematol. 42:e42–e44.
2020.PubMed/NCBI View Article : Google Scholar
|
15
|
Carretta A, Ciriaco P, Muriana P, Bandiera
A and Negri G: Surgical treatment of single and multiple thymoma
recurrences. Gen Thorac Cardiovasc Surg. 68:350–356.
2020.PubMed/NCBI View Article : Google Scholar
|
16
|
Hamaji M, Allen MS, Cassivi SD, Nichols FC
III, Wigle DA, Deschamps C and Shen KR: The role of surgical
management in recurrent thymic tumors. Ann Thorac Surg. 94:247–254.
2012.PubMed/NCBI View Article : Google Scholar
|
17
|
Miyata R, Hamaji M, Omasa M, Miyahara S,
Aoyama A, Takahashi Y, Sumitomo R, Huang CL, Hijiya K, Nakagawa T,
et al: The treatment and survival of patients with postoperative
recurrent thymic carcinoma and neuroendocrine carcinoma: A
multicenter retrospective study. Surg Today. 54:502–510.
2021.PubMed/NCBI View Article : Google Scholar
|